Search

everythinglearnresearchcommunity

for

Search:↓

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Testosterone's muscle-building effects do not require its conversion to DHT.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.